Filing Flows › ResMed (RMD) › Q4 FY26 › vs Q3 FY26
ResMed (RMD) Q4 FY26 vs Q3 FY26 (quarter over quarter)
ResMed's revenue rose $32.2M (+2%) from $1.4B in Q3 FY26 to $1.5B in Q4 FY26. The biggest changes: Sleep and Breathing Health +$31.2M (+2%); Residential Care Software +$1.0M (+0.6%). Gross margin 58.8% against 62.2% (-3.4 pts).
ResMed, Q4 FY26: revenue $1.5B (+9% year over year), operating margin 30.7%, net earnings $383M, operating cash flow $455M. The chart draws each line against Q3 FY26, the increases inside each band.
Margins
| Q4 FY26 | Q3 FY26 | Change | |
|---|---|---|---|
| Gross margin | 58.8% | 62.2% | -3.4 pts |
| Operating margin | 30.7% | 34.9% | -4.3 pts |
| Net margin | 26.2% | 27.9% | -1.7 pts |
| Free cash flow margin | 27.6% | 36.4% | -8.8 pts |
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Sleep and Breathing Health | $1.3B | $1.3B | $31.2M | +2% |
| Residential Care Software | $172M | $171M | $1.0M | +0.6% |
| Revenue | $1.5B | $1.4B | $32.2M | +2% |
| Gross profit | $861M | $891M | −$29.8M | -3% |
| Cost of revenue | $602M | $540M | $62.0M | +11% |
| Other income, net | $25.5M | $2.5M | $22.9M | +917% |
| Operating profit | $449M | $500M | −$51.1M | -10% |
| Operating expenses | $413M | $391M | $21.3M | +5% |
| Pre-tax earnings | $474M | $502M | −$28.1M | -6% |
| Research & development | $106M | $94.3M | $11.5M | +12% |
| SG&A | $296M | $286M | $10.6M | +4% |
| Other operating costs | $10.5M | $11.2M | −$748K | -7% |
| Net earnings | $383M | $399M | −$15.3M | -4% |
| Income tax | $90.7M | $104M | −$12.8M | -12% |
| Depreciation & amortization | $44.8M | $59.0M | −$14.2M | -24% |
| Share-based compensation | $27.5M | $26.8M | $666K | +2% |
| Working capital & other | $1.0M | −$69.6M | $70.7M | — |
| Operating cash flow | $455M | $554M | −$99.5M | -18% |
| Free cash flow (OCF − capex) | $404M | $520M | −$117M | -22% |
| Capital expenditures | $51.1M | $33.7M | $17.5M | +52% |
Questions
How much did ResMed's revenue grow quarter over quarter in Q4 FY26?
ResMed's revenue rose $32.2M (+2%) from $1.4B in Q3 FY26 to $1.5B in Q4 FY26.
What drove ResMed's revenue change in Q4 FY26?
Sleep and Breathing Health +$31.2M (+2%); Residential Care Software +$1.0M (+0.6%).